Vinay Prasad

Associate Professor

  • 2690 Citations
  • 26 h-Index
20092019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2009 2019

Filter
Short survey
2019

Interpreting the Effectiveness of Cancer Screening From National Population Statistics: Is It Sound Practice?

Chapa, J., Haslam, A. & Prasad, V., Jun 1 2019, In : Mayo Clinic Proceedings. 94, 6, p. 951-956 6 p.

Research output: Contribution to journalShort survey

Open Access
Population Characteristics
Early Detection of Cancer
2018
21 Citations (Scopus)

Cancer drugs approved based on biomarkers and not tumor type - FDA approval of pembrolizumab for mismatch repair-deficient solid cancers

Prasad, V., Kaestner, V. & Mailankody, S., Feb 1 2018, In : JAMA oncology. 4, 2, p. 157-158 2 p.

Research output: Contribution to journalShort survey

DNA Mismatch Repair
Tumor Biomarkers
Pharmaceutical Preparations
Neoplasms
pembrolizumab
2017
10 Citations (Scopus)

Health policy: Me-too drugs with limited benefits-the tale of regorafenib for HCC

Gyawali, B. & Prasad, V., Nov 1 2017, In : Nature Reviews Clinical Oncology. 14, 11, p. 653-654 2 p.

Research output: Contribution to journalShort survey

10 Citations (Scopus)

Overall survival in cancer drug trials as a new surrogate end point for overall survival in the real world

Mailankody, S. & Prasad, V., Jul 1 2017, In : JAMA oncology. 3, 7, p. 889-890 2 p.

Research output: Contribution to journalShort survey

Biomarkers
Pharmaceutical Preparations
Neoplasms
5 Citations (Scopus)

Pharmaceutical marketing for rare diseases: Regulating drug company promotion in an era of unprecedented advertisement

Mailankody, S. & Prasad, V., Jun 27 2017, In : JAMA - Journal of the American Medical Association. 317, 24, p. 2479-2480 2 p.

Research output: Contribution to journalShort survey

Medicine in Art
Patient Acceptance of Health Care
Pyrazoles
Janus Kinase 2
Drug Prescriptions
2016
15 Citations (Scopus)

Blood-based screening for colon cancer: A disruptive innovation or simply a disruption?

Parikh, R. B. & Prasad, V., Jun 21 2016, In : JAMA - Journal of the American Medical Association. 315, 23, p. 2519-2520 2 p.

Research output: Contribution to journalShort survey

Septins
Precancerous Conditions
Predictive Value of Tests
Colonoscopy
Feces
17 Citations (Scopus)

Implications of proposed medicare reforms to counteract high cancer drug prices

Mailankody, S. & Prasad, V., Jul 19 2016, In : JAMA - Journal of the American Medical Association. 316, 3, p. 271-272 2 p.

Research output: Contribution to journalShort survey

Financial Risk Sharing
Medicare Part B
Cost Sharing
Physicians' Practice Patterns
Incentive Reimbursement
10 Citations (Scopus)

The UK Cancer Drugs Fund Experiment and the US Cancer Drug Cost Problem: Bearing the Cost of Cancer Drugs Until It Is Unbearable

Prasad, V. & Mailankody, S., Jun 1 2016, In : Mayo Clinic Proceedings. 91, 6, p. 707-712 6 p.

Research output: Contribution to journalShort survey

Drug Costs
Pharmaceutical Preparations
Neoplasms
2009
2 Citations (Scopus)

Essays: Toward a meaningful alternative medicine

Prasad, V., Sep 2009, In : Hastings Center Report. 39, 5, p. 16-18 3 p.

Research output: Contribution to journalShort survey

Holistic Health
Integrated Delivery of Health Care
alternative medicine
Western World
Evidence-Based Medicine